Us Japan And Europe Computer Aided Detection Cad Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2025 –2031 |
 Taille du marché (année de référence) |
|
 Taille du marché (année de prévision) |
Dollars américains 3,609.06 |
 TCAC |
% |
| Principaux acteurs du marché |
>Marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe, par type de produit (logiciels et services), modalité d'imagerie (imagerie mammaire, imagerie pulmonaire, oncologie et radiothérapie, imagerie abdominale et pelvienne, imagerie dentaire, imagerie cardiovasculaire et autres), application (cancer, troubles neurologiques, maladies cardiovasculaires, maladies musculo-squelettiques et autres), mode d'achat (organisation d'achat groupé et individuel), utilisateur final (hôpitaux, centres de diagnostic, instituts de recherche et centres universitaires, et autres) - Tendances et prévisions de l'industrie jusqu'en 2031.
Analyse et taille du marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe
Le marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe devrait connaître une croissance du marché au cours de la période de prévision de 2024 à 2031.
Data Bridge Market Research analyse que le marché croît avec un TCAC de 12 % au cours de la période de prévision de 2024 à 2031 et devrait atteindre 3 609,06 millions USD d'ici 2031. La demande croissante de systèmes de CAO devrait stimuler l'expansion du marché.
|
Rapport métrique |
Détails |
|
Période de prévision |
2024 à 2031 |
|
Année de base |
2023 |
|
Année historique |
2022 (Personnalisable 2016-2021) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD et prix en USD |
|
Segments couverts |
Type de produit (logiciel et services), modalité d'imagerie ( imagerie mammaire , imagerie pulmonaire, oncologie et radiothérapie, imagerie abdominale et pelvienne, imagerie dentaire, imagerie cardiovasculaire et autres), application (cancer, troubles neurologiques, maladies cardiovasculaires, maladies musculo-squelettiques et autres), mode d'achat (organisation d'achat groupé et individuel), utilisateur final (hôpitaux, centres de diagnostic, instituts de recherche et centres universitaires et autres) |
|
Pays couverts |
États-Unis, Japon, Allemagne, Italie, Royaume-Uni, France, Suisse, Espagne, Russie, Turquie, Belgique, Pays-Bas et reste de l'Europe |
|
Acteurs du marché couverts |
CANON MEDICAL SYATEMA CORPORATION, Riverain Technologies, Koninklijke Philips NV, Seimens Healthineers AG, Hologic Inc., FUJIFILM Holdings Corporation, Median Technologies, General Electric Company, iCAD, and Inc., EDDA Technology, Inc. entre autres |
Définition du marché
Le terme « détection assistée par ordinateur » (DAO) décrit le processus d'interprétation des examens d'imagerie médicale, tels que les radiographies, les tomodensitogrammes et les IRM, à l'aide d'algorithmes et de logiciels informatiques. Les zones d'intérêt ou les anomalies possibles dans les images sont mises en évidence et signalées par les systèmes de DAO afin qu'un radiologue ou un autre professionnel de la santé puisse les examiner plus en détail. Ces systèmes analysent les motifs, les formes et les densités dans les images pour augmenter l'efficacité et la précision du diagnostic en mettant en évidence les zones qui pourraient nécessiter un examen plus approfondi. La DAO est un outil utile dans le processus de diagnostic qui aide les professionnels de la santé à comprendre et à prendre des décisions, même si elle ne peut pas remplacer les compétences humaines.
Dynamique du marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
Rising Application of Computer-Aided Detection (CAD) System in the Medical Field
The market for computer-aided detection (CAD) systems is growing and evolving due to the growing implementation of these systems in various medical disciplines. CAD systems were widely used in radiology to identify complexities in images, such as mammograms, but they have quickly spread to many other medical specialties. The growing use of CAD systems in specialty areas other than radiology—pathology, cardiology, oncology, and neurology—indicates their adaptability and effectiveness in supporting medical personnel in a variety of disciplines. Healthcare procedures are being revolutionized by CAD's capacity to provide early identification, precise diagnosis, and treatment planning for a variety of illnesses.
The increasing adoption and use of CAD systems in a range of medical specialties highlights their revolutionary influence on the provision of healthcare. The use of these systems in a variety of specializations is growing as they show promise in facilitating earlier and more accurate diagnoses, improved treatment outcomes, and improved patient care. Thus, the rising application of CAD system in medical field is driving market growth.
- Increasing Technological Advancements Associated with CAD
The primary factor behind the growth and expansion of the computer-aided detection (CAD) market in the healthcare sector is technological improvements. These developments keep CAD systems up to date and improve their adaptability, precision, and capacity for diagnosing a wide range of medical disorders. The development of deep learning algorithms, machine learning, and artificial intelligence (AI) has been essential to the advancement of CAD systems. These developments make it possible for CAD software to process enormous volumes of medical imaging data at previously unheard-of speeds and precision. This results in the more accurate and dependable identification of anomalies in MRIs, CT scans, X-rays, and other imaging modalities.
CAD systems will advance in detection, adaptability, and integration with healthcare ecosystems as technological advancements continue. The market is growing as a result of the CAD industry's unwavering application of technology improvements, which have the enormous potential to revolutionize patient care, improve diagnostic capabilities, and influence the direction of healthcare. Thus, the increasing technological advancements is driving market growth.
Opportunities
- Advanced Healthcare Infrastructure of the Countries
The advanced healthcare infrastructure in the U.S., Japan, and Europe is a factor for creating significant opportunities in the market. In the U.S., the well-established network of hospitals and diagnostic centers, coupled with sophisticated medical facilities, provides a fertile ground for the seamless integration of CAD technologies. The robust infrastructure accelerates the adoption of CAD systems, enhancing the efficiency and accuracy of medical imaging and diagnostics.
In all three regions, the advanced healthcare infrastructure not only establishes a foundation for the implementation of CAD but also reflects a commitment to leveraging cutting-edge technologies to enhance patient care. This commitment, combined with the technological readiness of healthcare systems, creates an environment where CAD can thrive, offering advanced diagnostic capabilities that contribute to more accurate and timely medical interventions, which is expected to create opportunities for market growth.
Restraints/Challenge
- High Cost of Computer Aided Detection (CAD) Systems
Many healthcare facilities find it difficult to integrate CAD systems into their diagnostic workflows due to the initial investment necessary for CAD system acquisition and implementation. Medical imaging-specific hardware and software are frequently needed for CAD systems. These systems might have expensive upfront costs, particularly for smaller healthcare facilities or those with tighter budgets.
The total cost of ownership includes additional expenses for continuing maintenance, updates, and licensing after the initial expenditure. The cost is increased by having to make sure the system is current with new developments and complies with legal requirements. It takes more time and resources to train healthcare workers on how to utilize CAD systems efficiently and seamlessly integrate them into current operations. There are expenses associated with this training for both the initial deployment and ongoing instruction as new features or updates are released.
Healthcare providers, especially smaller practices or institutions with limited funds, have been reluctant to use CAD systems due to their high cost. Patients' access to the advantages of CAD systems' more precise and effective diagnoses is restricted by this adoption barrier. The financial resources of healthcare institutions, particularly smaller practices or those with low resources, are strained by the cumulative effect of maintenance expenditures. Thus, the high cost of computer aided detection ((CAD) systems is restraining the market growth.
U.S., Japan and Europe Computer Aided Detection (CAD) Market Scope
The U.S., Japan & Europe Computer Aided Detection (CAD) Market is segmented into five notable segments based on product type, imaging modality, mode of purchase, and end user.
Product Type
- Software
- Services
On the basis of product type, the market is segmented software and services.
Imaging Modality
- Breast Imaging
- Lung Imaging
- Oncology and Radiation
- Abdominal and Pelvic Imaging
- Dental Imaging
- Cardiovascular Imaging
- Others
On the basis of imaging modality, the market is segmented into breast imaging, lung imaging, oncology and radiation, abdominal and pelvic imaging, dental imaging, cardiovascular imaging, and others.
Application
- Cancer
- Neurological Disorders
- Cardiovascular Diseases
- Musculoskeletal Diseases
- Others
On the basis of application, the market is segmented into cancer, neurological disorders, cardiovascular diseases, musculoskeletal diseases, and others.
Mode of Purchase
- Group Purchase Organization
- Individual
On the basis of mode of purchase, the market is segmented into group purchase organization and individual.
End User
- Hospitals
- Diagnostic Centers
- Research Institutes and Academic Centers
- Others
On the basis of end user, the market is segmented into hospitals, diagnostic centers, research institutes and academic centers, and others.
U.S., Japan and Europe Computer Aided Detection (CAD) Market Regional Analysis/Insights
The U.S., Japan & Europe Computer Aided Detection (CAD) market is analyzed, and market size insights and trends are provided by based on product type, imaging modality, application, mode of purchase, and end user.
The countries covered in the U.S., Japan & Europe Computer Aided Detection (CAD) Market report are U.S., Germany, Italy, U.K., France, Switzerland, Spain, Russia, Turkey, Belgium, Netherlands, and rest of Europe.
U.S. is expected to dominate the North American market because the U.S. is one of the world's largest producers of CAD systems. Japan is expected to dominate the Asia-Pacific market due to it has a long history of medical technologies. Germany is expected to dominate the market due to German medical professionals often employ modern and efficient CAD practices, which can lead to higher sales and better-quality CAD.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and U.S., Japan and Europe Computer Aided Detection (CAD) Market Share Analysis
Le paysage concurrentiel du marché américain, japonais et européen de la détection assistée par ordinateur (CAO) fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises sur le marché américain, japonais et européen de la détection assistée par ordinateur (CAO).
Certains des principaux acteurs opérant sur le marché de la détection assistée par ordinateur (CAO) aux États-Unis, au Japon et en Europe sont CANON MEDICAL SYATEMA CORPORATION, Riverain Technologies, Koninklijke Philips NV, Seimens Healthineers AG, Hologic Inc., FUJIFILM Holdings Corporation, Median Technologies, General Electric Company, iCAD, and Inc., EDDA Technology, Inc.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 MULTIVARIATE MODELLING
2.8 TYPE LIFELINE CURVE
2.9 MARKET END USER COVERAGE GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL
4.2 PORTERS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING APPLICATION OF COMPUTER-AIDED DETECTION (CAD) SYSTEM IN MEDICAL FIELD
5.1.2 INCREASING TECHNOLOGICAL ADVANCEMENTS ASSOCIATED WITH CAD
5.1.3 GOVERNMENT INITIATIVES FOR COMPUTER AIDED DETECTION (CAD) SYSTEMS
5.2 RESTRAINTS
5.2.1 HIGH COST OF COMPUTER AIDED DETECTION (CAD) SYSTEMS
5.2.2 STRICT GUIDELINES FOR COMPUTER AIDED DETECTION (CAD)
5.3 OPPORTUNITIES
5.3.1 ADVANCED HEALTHCARE INFRASTRUCTURE OF THE COUNTRIES
5.3.2 INCREASING AWARENESS REGARDING ACCURATE DIAGNOSIS
5.4 CHALLENGE
5.4.1 DEPENDENCY ON SKILLED MEDICAL PROFESSIONALS
6 US, JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 SOFTWARE
6.2.1 INTEGRATED CAD SYSTEMS
6.2.1.1 CLOUD BASED
6.2.1.2 ON PREMISES
6.2.2 STANDALONE CAD SYSTEMS
6.2.2.1 CLOUD BASED
6.2.2.2 ON PREMISES
6.3 SERVICES
7 US, JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY
7.1 OVERVIEW
7.2 ONCOLOGY AND RADIATION
7.2.1 BY TYPE
7.2.1.1 ONCOLOGY CAD
7.2.1.2 RADIATION THERAPY PLANNING
7.2.2 BY TUMOR TYPE
7.2.2.1 MALIGNANT
7.2.2.2 BENIGN
7.2.3 BY PRODUCT TYPE
7.2.3.1 SOFTWARE
7.2.3.2 SERVICES
7.3 BREAST IMAGING
7.3.1 BY TYPE
7.3.1.1 MAMMOGRAPHY CAD
7.3.1.2 BREAST ULTRASOUND CAD
7.3.2 BY PRODUCT TYPE
7.3.2.1 SOFTWARE
7.3.2.2 SERVICES
7.4 LUNG IMAGING
7.4.1 BY TYPE
7.4.1.1 CHEST X-RAY CAD
7.4.1.2 CHEST CT CAD ON PULMONARY NODULES
7.4.2 BY NODULE SIZE
7.4.2.1 >4MM AND <5MM
7.4.2.2 >5MM
7.4.2.3 3 MM AND < 4MM
7.4.3 BY NODULE
7.4.3.1 PART SOLID NODULES
7.4.3.2 NON- SOLID NODULES
7.4.4 BY NODULE TYPE
7.4.4.1 JUXTAPLEURAL NODULES
7.4.4.2 ISOLATED NODULES
7.4.4.3 GROUND-GLASS NODULES
7.4.5 BY PRODUCT TYPE
7.4.5.1 SOFTWARE
7.4.5.2 SERVICES
7.5 CARDIOVASCULAR IMAGING
7.5.1 BY TYPE
7.5.1.1 CARDIAC CT CAD
7.5.1.2 CARDIAC MT CAD
7.5.2 BY PRODUCT TYPE
7.5.2.1 SOFTWARE
7.5.2.2 SERVICES
7.6 ABDOMINAL AND PELVIC IMAGING
7.6.1 BY TYPE
7.6.1.1 GASTROINTESTINAL CAD
7.6.1.2 ABDOMINAL CT CAD
7.6.1.3 KIDNEY CAD
7.6.2 BY PRODUCT TYPE
7.6.2.1 SOFTWARE
7.6.2.2 SERVICES
7.7 DENTAL IMAGING
7.7.1 BY PRODUCT TYPE
7.7.1.1 SOFTWARE
7.7.1.2 SERVICES
7.8 OTHERS
8 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 CANCER
8.2.1 BY TYPE
8.2.1.1 BREAST CANCER
8.2.1.2 COLORECTAL CANCER
8.2.1.3 LUNG CANCER
8.2.1.4 PROSTATE CANCER
8.2.1.5 LIVER CANCER
8.2.1.6 BONE CANCER
8.2.1.7 OTHERS
8.2.2 BY PRODUCT TYPE
8.2.2.1 SOFTWARE
8.2.2.2 SERVICES
8.3 NEUROLOGICAL DISORDERS
8.3.1 BY TYPE
8.3.1.1 MULTIPLE SCLEROSIS
8.3.1.2 STROKE
8.3.1.3 OTHERS
8.3.2 BY PRODUCT TYPE
8.3.2.1 SOFTWARE
8.3.2.2 SERVICES
8.4 CARDIOVASCULAR DISEASES
8.4.1 BY TYPE
8.4.1.1 CORONARY ARTERY DISEASE
8.4.1.2 CONGENITAL HEART DEFECTS
8.4.1.3 VALVULAR HEART DISEASE
8.4.1.4 OTHERS
8.4.2 BY PRODUCT TYPE
8.4.2.1 SOFTWARE
8.4.2.2 SERVICES
8.5 MUSCULOSKELETAL DISEASES
8.5.1 BY TYPE
8.5.1.1 OSTEOARTHRITIS
8.5.1.2 RHEUMATOID ARTHRITIS
8.5.1.3 JOINT DISORDERS
8.5.1.4 OTHERS
8.6 OTHERS
9 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE
9.1 OVERVIEW
9.2 GROUP PURCHASE ORGANIZATIONS
9.3 INDIVIDUAL
10 US, JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 PRIVATE
10.2.2 PUBLIC
10.3 DIAGNOSTIC CENTERS
10.4 RESEARCH CENTERS & ACADEMIC INSTITUTES
10.5 OTHERS
11 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET BY REGION
11.1 EUROPE
11.1.1 GERMANY
11.1.2 FRANCE
11.1.3 U.K.
11.1.4 SPAIN
11.1.5 ITALY
11.1.6 NETHERLANDS
11.1.7 BELGIUM
11.1.8 SWITZERLAND
11.1.9 RUSSIA
11.1.10 TURKEY
11.1.11 REST OF EUROPE
12 COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: U.S., JAPAN & EUROPE
12.2 COMPANY SHARE ANALYSIS: U.S.
12.3 COMPANY SHARE ANALYSIS: JAPAN
12.4 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 KONINKLIJKE PHILIPS N.V.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENT
14.2 FUJIFILM HOLDINGS CORPORATION
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENT
14.3 CANON MEDICAL SYSTEMS CORPORATION
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENT
14.4 SIEMENS HEALTHINEERS AG
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENT
14.5 MEDIAN TECHNOLOGIES.
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.6 EDDA TECHNOLOGY, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 GENERAL ELECTRIC
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENT
14.8 HOLOGIC INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 ICAD, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCT PORTFOLIO
14.9.4 RECENT DEVELOPMENT
14.1 RIVERAIN TECHNOLOGIES
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
Liste des tableaux
TABLE 1 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2023- 2031 (USD MILLION)
TABLE 2 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2023-2031 (USD MILLION)
TABLE 3 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2023-2031 (USD MILLION)
TABLE 4 U.S. SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 5 JAPAN SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 6 EUROPE SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 7 U.S. INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 8 JAPAN INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 9 EUROPE INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 10 U.S. STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 11 JAPAN STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 12 EUROPE STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 13 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2023- 2031 (USD MILLION)
TABLE 14 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2023-2031 (USD MILLION)
TABLE 15 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2023-2031 (USD MILLION)
TABLE 16 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 17 JAPAN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 18 EUROPE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)
TABLE 19 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 20 JAPAN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 21 EUROPE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2021-2031 (USD MILLION)
TABLE 22 U.S. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 23 JAPAN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 24 EUROPE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2021-2031 (USD MILLION)
TABLE 25 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 26 JAPAN BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 27 EUROPE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)
TABLE 28 U.S. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 29 JAPAN BRESAT IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 30 EUROPE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)
TABLE 31 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 32 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 33 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)
TABLE 34 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 35 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 36 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2021-2031 (USD MILLION)
TABLE 37 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 38 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE , 2022-2031 (USD MILLION)
TABLE 39 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2021-2031 (USD MILLION)
TABLE 40 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 41 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 42 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2021-2031 (USD MILLION)
TABLE 43 U.S. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 44 JAPAN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 45 EUROPE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)
TABLE 46 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 47 JAPAN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 48 EUROPE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)
TABLE 49 U.S. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 50 JAPAN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 51 EUROPE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)
TABLE 52 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 53 JAPAN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 54 EUROPE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2021-2031 (USD MILLION)
TABLE 55 U.S. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 56 JAPAN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 57 EUROPE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)
TABLE 58 U.S. DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 59 JAPAN DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 60 EUROPE DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2021-2031 (USD MILLION)
TABLE 61 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2023- 2031 (U.S.D MILLION)
TABLE 62 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2023-2031 (U.S.D MILLION)
TABLE 63 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2023-2031 (U.S.D MILLION)
TABLE 64 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 65 JAPAN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 66 EUROPE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 67 U.S. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 68 JAPAN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 69 EUROPE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 70 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 71 JAPAN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 72 EUROPE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 73 U.S. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 74 JAPAN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 75 EUROPE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 76 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 77 U.S. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 78 JAPAN CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 79 EUROPE CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 80 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 81 JAPAN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 82 EUROPE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (U.S.D MILLION)
TABLE 83 U.S. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 84 JAPAN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 85 EUROPE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (U.S.D MILLION)
TABLE 86 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2023- 2031 (USD MILLION)
TABLE 87 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2023-2031 (USD MILLION)
TABLE 88 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2023-2031 (USD MILLION)
TABLE 89 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 90 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 91 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 92 U.S. HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 93 JAPAN HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 94 EUROPE HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 95 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 96 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 97 GERMANY SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 98 GERMANY INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 99 GERMANY STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 100 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 101 GERMANY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 102 GERMANY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 103 GERMANY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 104 GERMANY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 105 GERMANY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 106 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 107 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 108 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 109 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 110 GERMANY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 111 GERMANY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 112 GERMANY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 113 GERMANY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 114 GERMANY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 115 GERMANY DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 116 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 117 GERMANY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 118 GERMANY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 119 GERMANY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 120 GERMANY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 121 GERMANY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 122 GERMANY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 123 GERMANY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 124 GERMANY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 125 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 126 GERMANY COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 127 GERMANY HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 128 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 129 FRANCE SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 130 FRANCE INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 131 FRANCE STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 132 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 133 FRANCE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 134 FRANCE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 135 FRANCE ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 136 FRANCE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 137 FRANCE BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 138 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 139 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 140 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 141 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 142 FRANCE LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 143 FRANCE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 144 FRANCE CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 145 FRANCE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 146 FRANCE ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 147 FRANCE DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 148 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 149 FRANCE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 150 FRANCE CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 151 FRANCE CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 152 FRANCE CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 153 FRANCE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 154 FRANCE MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 155 FRANCE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 156 FRANCE NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 157 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 158 FRANCE COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 159 FRANCE HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 160 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 161 U.K. SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 162 U.K. INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 163 U.K. STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 164 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 165 U.K. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 166 U.K. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 167 U.K. ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 168 U.K. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 169 U.K. BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 170 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 171 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 172 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 173 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 174 U.K. LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 175 U.K. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 176 U.K. CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 177 U.K. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 178 U.K. ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 179 U.K. DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 180 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 181 U.K. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 182 U.K. CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 183 U.K. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 184 U.K. CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 185 U.K. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 186 U.K. MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 187 U.K. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 188 U.K. NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 189 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 190 U.K. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 191 U.K. HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 192 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 193 SPAIN SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 194 SPAIN INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 195 SPAIN STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 196 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 197 SPAIN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 198 SPAIN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 199 SPAIN ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 200 SPAIN BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 201 SPAIN BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 202 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 203 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 204 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 205 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 206 SPAIN LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 207 SPAIN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 208 SPAIN CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 209 SPAIN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 210 SPAIN ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 211 SPAIN DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 212 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 213 SPAIN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 214 SPAIN CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 215 SPAIN CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 216 SPAIN CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 217 SPAIN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 218 SPAIN MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 219 SPAIN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 220 SPAIN NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 221 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 222 SPAIN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 223 SPAIN HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 224 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 225 ITALY SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 226 ITALY INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 227 ITALY STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 228 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 229 ITALY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 230 ITALY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 231 ITALY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 232 ITALY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 233 ITALY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 234 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 235 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 236 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 237 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 238 ITALY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 239 ITALY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 240 ITALY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 241 ITALY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 242 ITALY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 243 ITALY DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 244 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 245 ITALY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 246 ITALY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 247 ITALY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 248 ITALY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 249 ITALY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 250 ITALY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 251 ITALY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 252 ITALY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 253 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 254 ITALY COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 255 ITALY HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 256 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 257 NETHERLANDS SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 258 NETHERLANDS INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 259 NETHERLANDS STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 260 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 261 NETHERLANDS ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 262 NETHERLANDS ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 263 NETHERLANDS ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 264 NETHERLANDS BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 265 NETHERLANDS BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 266 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 267 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 268 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 269 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 270 NETHERLANDS LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 271 NETHERLANDS CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 272 NETHERLANDS CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 273 NETHERLANDS ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 274 NETHERLANDS ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 275 NETHERLANDS DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 276 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 277 NETHERLANDS CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 278 NETHERLANDS CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 279 NETHERLANDS CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 280 NETHERLANDS CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 281 NETHERLANDS MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 282 NETHERLANDS MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 283 NETHERLANDS NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 284 NETHERLANDS NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 285 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 286 NETHERLANDS COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 287 NETHERLANDS HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 288 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 289 BELGIUM SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 290 BELGIUM INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 291 BELGIUM STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 292 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 293 BELGIUM ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 294 BELGIUM ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 295 BELGIUM ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 296 BELGIUM BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 297 BELGIUM BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 298 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 299 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 300 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 301 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 302 BELGIUM LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 303 BELGIUM CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 304 BELGIUM CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 305 BELGIUM ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 306 BELGIUM ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 307 BELGIUM DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 308 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 309 BELGIUM CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 310 BELGIUM CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 311 BELGIUM CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 312 BELGIUM CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 313 BELGIUM MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 314 BELGIUM MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 315 BELGIUM NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 316 BELGIUM NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 317 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 318 BELGIUM COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 319 BELGIUM HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 320 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 321 SWITZERLAND SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 322 SWITZERLAND INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 323 SWITZERLAND STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 324 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 325 SWITZERLAND ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 326 SWITZERLAND ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 327 SWITZERLAND ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 328 SWITZERLAND BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 329 SWITZERLAND BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 330 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 331 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 332 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 333 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 334 SWITZERLAND LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 335 SWITZERLAND CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 336 SWITZERLAND CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 337 SWITZERLAND ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 338 SWITZERLAND ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 339 SWITZERLAND DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 340 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 341 SWITZERLAND CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 342 SWITZERLAND CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 343 SWITZERLAND CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 344 SWITZERLAND CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 345 SWITZERLAND MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 346 SWITZERLAND MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 347 SWITZERLAND NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 348 SWITZERLAND NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 349 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 350 SWITZERLAND COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 351 SWITZERLAND HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 352 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 353 RUSSIA SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 354 RUSSIA INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 355 RUSSIA STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 356 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 357 RUSSIA ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 358 RUSSIA ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 359 RUSSIA ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 360 RUSSIA BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 361 RUSSIA BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 362 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 363 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 364 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 365 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 366 RUSSIA LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 367 RUSSIA CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 368 RUSSIA CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 369 RUSSIA ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 370 RUSSIA ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 371 RUSSIA DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 372 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 373 RUSSIA CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 374 RUSSIA CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 375 RUSSIA CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 376 RUSSIA CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 377 RUSSIA MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 378 RUSSIA MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 379 RUSSIA NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 380 RUSSIA NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 381 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 382 RUSSIA COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 383 RUSSIA HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 384 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 385 TURKEY SOFTWARE IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 386 TURKEY INTEGRATED CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 387 TURKEY STANDALONE CAD IN COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF DEPLOYMENT, 2022-2031 (USD MILLION)
TABLE 388 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY, 2022-2031 (USD MILLION)
TABLE 389 TURKEY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 390 TURKEY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TUMOR TYPE, 2022-2031 (USD MILLION)
TABLE 391 TURKEY ONCOLOGY AND RADIATION IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 392 TURKEY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 393 TURKEY BREAST IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 394 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 395 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE SIZE, 2022-2031 (USD MILLION)
TABLE 396 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE, 2022-2031 (USD MILLION)
TABLE 397 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY NODULE TYPE, 2022-2031 (USD MILLION)
TABLE 398 TURKEY LUNG IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 399 TURKEY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 400 TURKEY CARDIOVASCULAR IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 401 TURKEY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 402 TURKEY ABDOMINAL AND PELVIC IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 403 TURKEY DENTAL IMAGING IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 404 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 405 TURKEY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 406 TURKEY CANCER IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 407 TURKEY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 408 TURKEY CARDIOVASCULAR DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 409 TURKEY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 410 TURKEY MUSCULOSKELETAL DISEASES IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 411 TURKEY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 412 TURKEY NEUROLOGICAL DISORDERS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 413 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE, 2022-2031 (USD MILLION)
TABLE 414 TURKEY COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 415 TURKEY HOSPITALS IN COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 416 REST OF EUROPE COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
Liste des figures
FIGURE 1 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION
FIGURE 2 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: DATA TRIANGULATION
FIGURE 3 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: DROC ANALYSIS
FIGURE 4 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: REGIONAL AND COUNTRY LEVEL MARKET ANALYSIS
FIGURE 5 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: COUNTRY LEVEL MARKET ANALYSIS
FIGURE 6 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: REGIONAL AND COUNTRY LEVEL MARKET ANALYSIS
FIGURE 7 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 8 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 9 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: DBMR MARKET POSITION GRID
FIGURE 10 JAPAN LIFELINE CURVE
FIGURE 11 EUROPE LIFELINE CURVE
FIGURE 12 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: MARKET END USER COVERAGE GRID
FIGURE 13 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: SEGMENTATION
FIGURE 14 INCREASING TECHNOLOGICAL ADVANCEMENTS IS DRIVING THE GROWTH OF U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031
FIGURE 16 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031
FIGURE 17 SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031
FIGURE 18 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031
FIGURE 19 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET IN 2024 & 2031
FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET
FIGURE 21 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023
FIGURE 22 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023
FIGURE 23 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2023
FIGURE 24 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)
FIGURE 25 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)
FIGURE 26 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)
FIGURE 27 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, CAGR (2024-2031)
FIGURE 28 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE CAGR (2024-2031)
FIGURE 29 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, CAGR (2024-2031)
FIGURE 30 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 31 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 32 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 33 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2023
FIGURE 34 JAPAN ORTHOTIC DEVICES MARKET: BY IMAGING MODALITY, 2023
FIGURE 35 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2023
FIGURE 36 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)
FIGURE 37 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)
FIGURE 38 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, 2024-2031 (USD MILLION)
FIGURE 39 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, CAGR (2024-2031)
FIGURE 40 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY CAGR (2024-2031)
FIGURE 41 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, CAGR (2024-2031)
FIGURE 42 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE
FIGURE 43 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE
FIGURE 44 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY IMAGING MODALITY, LIFELINE CURVE
FIGURE 45 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023
FIGURE 46 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023
FIGURE 47 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2023
FIGURE 48 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (U.S.D MILLION)
FIGURE 49 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (U.S.D MILLION)
FIGURE 50 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, 2024-2031 (U.S.D MILLION)
FIGURE 51 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 52 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION CAGR (2024-2031)
FIGURE 53 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 54 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 55 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 56 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 57 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023
FIGURE 58 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023
FIGURE 59 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2023
FIGURE 60 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
FIGURE 61 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
FIGURE 62 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, 2024-2031 (USD MILLION)
FIGURE 63 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)
FIGURE 64 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE CAGR (2024-2031)
FIGURE 65 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, CAGR (2024-2031)
FIGURE 66 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 67 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 68 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 69 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023
FIGURE 70 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023
FIGURE 71 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2023
FIGURE 72 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 73 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 74 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 75 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)
FIGURE 76 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)
FIGURE 77 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, CAGR (2024-2031)
FIGURE 78 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE
FIGURE 79 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE
FIGURE 80 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: BY END USER, LIFELINE CURVE
FIGURE 81 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: SNAPSHOT (2023)
FIGURE 82 U.S., JAPAN & EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)
FIGURE 83 U.S. COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)
FIGURE 84 JAPAN COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)
FIGURE 85 EUROPE COMPUTER AIDED DETECTION (CAD) MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
